Literature DB >> 9929761

Therapeutic myocardial angiogenesis using percutaneous intrapericardial drug delivery.

R J Laham1, D Hung, M Simons.   

Abstract

In this manuscript, we describe the potential role of the pericardial space as a drug delivery reservoir to administer angiogenic agents to the heart resulting in functionally significant angiogenesis with single bolus basic fibroblast growth factor (bFGF) delivery. We also describe a percutaneous subxyphoid pericardial access technique that is safe, rapid, and reliable.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 9929761     DOI: 10.1002/clc.4960221305

Source DB:  PubMed          Journal:  Clin Cardiol        ISSN: 0160-9289            Impact factor:   2.882


  3 in total

1.  Pericardial approach for cardiac therapies: old practice with new ideas.

Authors:  Seongwook Han; Chun Hwang
Journal:  Korean Circ J       Date:  2010-10-31       Impact factor: 3.243

2.  Cloning and bacterial expression of postnatal mouse heart FGF-16.

Authors:  David P Sontag; Peter A Cattini
Journal:  Mol Cell Biochem       Date:  2003-01       Impact factor: 3.396

3.  Therapeutic payload delivery to the myocardium: Evolving strategies and obstacles.

Authors:  Tarek Shazly; Arianna Smith; Mark J Uline; Francis G Spinale
Journal:  JTCVS Open       Date:  2022-05-05
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.